Posted: 18 August 2026 - Nantes, France
The Inserm Chair in Immunotherapy at Nantes University seeks an emerging leader in adoptive T cell-based immunotherapy. The position offers a 5-year contract with a fast track to tenure as a Research Director. The successful candidate will develop innovative therapies for cancer, focusing on T cell biology and therapeutic strategies. The role includes teaching responsibilities and aims to enhance the research profile of the INCIT unit. The position is funded with a starting package of 200k EUR for research initiation.